Suppr超能文献

头颈部鳞状细胞癌的咽切开术:功能与肿瘤学方面

Pharyngotomy in head and neck squamous cell carcinoma: functional and oncological aspects.

作者信息

Remmert Carolin, Mansour Naglaa, Hofauer Benedikt, Scherer Elias Q, Bas Murat, Bier Henning, Knopf Andreas

机构信息

a Department of Otorhinolaryngology/Head and Neck Surgery , Klinikum rechts der s Isar, Technische Universität München , München , Germany.

b Department of Otorhinolaryngology/Head and Neck Surgery , Agaplesion Diakonieklinikum Rotenburg , Rotenburg ( Wümme ), Germany.

出版信息

Acta Otolaryngol. 2017 Dec;137(12):1281-1287. doi: 10.1080/00016489.2017.1355564. Epub 2017 Jul 25.

Abstract

BACKGROUND

Head and Neck Surgery constantly has to oppose non-invasive organ preservation methods and therefore should be evaluated especially with regard to clinical and functional outcome. We will discuss the role of pharyngotomy in the treatment of HNSCC.

METHODS

Seventy-three patients with carcinoma of the oral cavity, oro-/hypopharynx and supraglottis underwent lateral/median pharyngotomy. Functional and oncological parameters were retrospectively assessed and set into clinical context.

RESULTS

The 5-year recurrence-free-interval (RFI) was significantly higher with surgery and adjuvant radio(chemo)therapy (80%; mean RFI: 92 months) when compared to conservative treatment (68%; mean RFI: 68 months). The 5-year overall-survival (OS) after surgery and conservative treatment was 71% and 54%, respectively. Compared to other surgical techniques (mean RFI: 82 months), pharyngotomy demonstrated a significant higher 5-year RFI (mean RFI: 89 months).

CONCLUSIONS

Pharyngotomy achieves good exposure and clear resection margins that result in a notably good oncological outcome with a minimum of functional loss. In particular, among UICC IV oropharyngeal HNSCC, pharyngotomy is superior in OS and RFI to conservative methods.

摘要

背景

头颈外科手术一直需要应对非侵入性器官保留方法,因此尤其应从临床和功能结果方面进行评估。我们将讨论咽切开术在头颈部鳞状细胞癌(HNSCC)治疗中的作用。

方法

73例口腔、口咽/下咽和声门上癌患者接受了外侧/正中咽切开术。对功能和肿瘤学参数进行回顾性评估,并结合临床情况进行分析。

结果

与保守治疗(68%;平均无复发生存期[RFI]:68个月)相比,手术联合辅助放(化)疗后的5年无复发生存期(RFI)显著更高(80%;平均RFI:92个月)。手术和保守治疗后的5年总生存率(OS)分别为71%和54%。与其他手术技术(平均RFI:82个月)相比,咽切开术的5年RFI显著更高(平均RFI:89个月)。

结论

咽切开术能实现良好的暴露和清晰的切缘,从而在功能损失最小的情况下取得显著良好的肿瘤学结果。特别是在国际抗癌联盟(UICC)IV期口咽HNSCC中,咽切开术在总生存率和无复发生存期方面优于保守方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验